The effects of elevated blood lead levels and succimer chelation therapy on physical growth in developing rhesus monkeys

Environmental Research

Volumn 87, Issue 1, 2001, Pages 21-30

  Lasky, Robert E ^a   Laughlin, Nellie K ^b   Luck, Melissa L ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Head circumference; Lead; Length; Succimer; Weight

Indexed keywords

SUCCIMER;

LEAD; PRIMATE;

ANIMAL EXPERIMENT; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHELATION THERAPY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GROWTH; HEAD CIRCUMFERENCE; LEAD BLOOD LEVEL; LEAD POISONING; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RHESUS MONKEY; TREATMENT OUTCOME;

MACACA MULATTA;

EID: 0034831102     PISSN: 00139351     EISSN: None     Source Type: Journal    
DOI: 10.1006/enrs.2001.4278     Document Type: Article

References (51)

1. Increased erthyrocyte protoporphyrins and blood lead: A pilot study of childhood growth patterns
2. Meso-2,3-dimercaptosuccinic acid: Chemical, pharmacological and toxicological properties of an orally effective metal chelating agent
3. Blood lead concentration and children's anthropometric dimensions in the third national health and nutrition survey (NHANES III), 1988-1994
4. Elevated lead levels in children with nonorganic failure to thrive
5. The effects of lactose on the absorption and retention of dietary lead
6. Hazards to health from environmental lead exposure: A review of recent literature
7. Effect of exposure to low level lead on growth and growth hormone release in rats
8. BAL, EDTA, DMSA and DMPS in the treatment of lead poisoning in children
9. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy
10. Effects of succimer on regional brain Pb levels in primates
11. Human fetal lead exposure: Intrauterine growth, maturation and postnatal neurobehavioral development
12. 2,3-Dimercaptosuccinic acid treatment of heavy metal poisoning in humans
13. Decreased stature associated with moderate blood lead concentrations in Mexican-American children
14. Effect of chelation with mesodimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat
15. Role of chelating agents for prevention, intervention and treatment of exposure to toxic metals
16. Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning
17. 2,3-Dimercaptosuccinic acid: A new agent for the treatment of lead poisoning
18. Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations
19. 2,3-Dimercaptosuccinic acid as an antidote for lead intoxication
20. Prenatal and preschool age led exposure: Relationship with size
21. Influence of lead on mineralization during bone growth
22. Neuroendocrine effects of toxic and low blood lead levels in children
23. Diets and blood lead levels of children who practice pica
24. Effects of lead on the somatic growth of children
25. Lead exposure and diet: Differential effects on social development in the rhesus monkey
26. Comparison of biometric data of children with high and low levels of lead in the blood
27. Behavioral effects of developmental lead exposure in rhesus monkeys
28. Perspectives on lead toxicity
29. Lead intoxication alters basal and parathyroid hormone-regulated cellular calcium homeostasis in rat osteosarcoma (ROS 17/2.8) cells
30. Lead perturbs epidermal growth factor (EGF) modulation of intracellular calcium metabolism and collagen synthesis in clonal rat osteoblastic (ROS 17/2.8) cells
31. Changes in uptake of lead over weaning in infant rhesus monkeys
32. Determination of lead in blood using electrothermal atomization atomic absorption spectrometry with a L'vov platform and matrix modifier
33. Age determination of the fetal and neonatal pigtailed macaque (Macaca nemistriua) from somatometric measurements
34. Oral dimercaptosuccinic acid and ongoing exposure to lead: Effects on heme synthesis and lead distribution in a rat model
35. Effects of long-term lead exposure on hematology, blood chemistry, and growth curves in monkeys
36. Neurobehavioral deficits after low level lead exposure in neonates: The Mexico City pilot study
37. Pre- and postnatal lead effect on head circumference: A case for critical periods
38. Factores relacionados con el nivel de plomo en sangre en ninos de 6 a 30 meses de edad en el estudio prospective de plomo en la Ciudad de Mexico
39. Relationship between childhood blood lead levels and stature
40. Fetal and infant lead exposure: Effects on growth in stature
41. Stable isotopic tracers of lead mobilized by DMSA chelation in low lead-exposed rats
42. 204Pb
43. Reduction of tissue Pb with succimer chelation in rhesus monkeys
44. The Treatment of Lead-exposed Children (TLC) trial: Design and recruitment for a study of the effect of oral chelation on growth and development in toddlers
45. Chronic effects of lead in nonhuman primates
46. Comparative mobilization of lead by chelating agents